No Data
No Data
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal
BioPharma Credit (BPCR.L) committed to providing up to $10 million in additional funding to LumiraDx amid the extension in the latter's sale of businesses to Swiss pharmaceutical and diagnostics compa
Roche, LumiraDx Deal Probed by U.K. Competition Watchdog
By Michael Susin The U.K. Competition and Markets Authority said it launched a merger inquiry regarding whether a deal for Roche Holding to buy certain companies linked to LumiraDx's point-of-care te
Express News | Cma Announced Launch of Its Merger Inquiry on Roche/Lumiradx by Notice to Parties on 23 May 2024 and Has a Deadline of 19 July 2024 for Its Phase 1 Decision
Express News | Competitiona and Market Authority: Says Start of Cma Merger Investigation: Roche / Lumiradx
CMA Invites Views From Interested Parties On Roche, LumiraDx Deal
U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx
By Mauro Orru The U.K.'s Competition and Markets Authority is considering whether a deal for Roche Holding to buy certain companies linked to LumiraDx's point-of-care technology could stifle competit
No Data
Chris 820 : I'm with ya bro
WAITFOR88 : count me in, too.